Insider · CIK 0001837586
Kimberly Kraig Thompson
Files at KBLB (Kraig Biocraft Laboratories, Inc.). First filing -, latest -.
Kimberly Kraig Thompson files SEC Form 4 as CEO, director and 10% owner at KBLB (Kraig Biocraft Laboratories, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kimberly Kraig Thompson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | KBLB Kraig Biocraft Laboratories, Inc. | WWill or inheritance Common Stock | +27,500 | $0.09 | $2,492 | 201,677,922 | Apr 10, 2025 |
| Mar 31, 2025 | KBLB Kraig Biocraft Laboratories, Inc. | WWill or inheritance Common Stock | +62,500 | $0.09 | $5,663 | 201,650,422 | Apr 8, 2025 |
Questions about Kimberly Kraig Thompson
Answered from the filings on this page, as of the latest one.
Is Kimberly Kraig Thompson buying or selling?
Kimberly Kraig Thompson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kimberly Kraig Thompson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kimberly Kraig Thompson has 0.
Where does Kimberly Kraig Thompson file Form 4?
Kimberly Kraig Thompson has filed Form 4 at KBLB (Kraig Biocraft Laboratories, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.